Subgroup-Specific Prognostic Implications of <i>TP53</i> Mutation in MedulloblastomaNataliya Zhukova, Rebecca M. Hill, David Shih et al.|Journal of Clinical Oncology|2013Cited by 488
Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysisEric M. Thompson, Tibor Hortobágyi, Thomas Hielscher et al.|The Lancet Oncology|2016Cited by 369